Active surveillance for prostate cancer: current evidence and contemporary state of practice

JJ Tosoian, HB Carter, A Lepor, S Loeb - Nature Reviews Urology, 2016 - nature.com
Prostate cancer remains one of the most commonly diagnosed malignancies worldwide.
Early diagnosis and curative treatment seem to improve survival in men with unfavourable …

Active surveillance for prostate cancer: a narrative review of clinical guidelines

SM Bruinsma, CH Bangma, PR Carroll… - Nature Reviews …, 2016 - nature.com
In the past decade active surveillance (AS) of men with localized prostate cancer has
become an increasingly popular management option, and a range of clinical guidelines …

Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: the role of systematic and targeted biopsies

CP Filson, S Natarajan, DJA Margolis, J Huang… - Cancer, 2016 - Wiley Online Library
BACKGROUND The current study was conducted to evaluate the performance of magnetic
resonance (MR)‐ultrasound‐guided fusion biopsy in diagnosing clinically significant …

A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment

LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi… - European urology, 2016 - Elsevier
Abstract Background The Prostate Cancer Research International Active Surveillance
(PRIAS) study was initiated a decade ago to study the most optimal selection and follow-up …

Long-term results of active surveillance in the Göteborg randomized, population-based prostate cancer screening trial

RA Godtman, E Holmberg, A Khatami, CG Pihl… - European urology, 2016 - Elsevier
Background Active surveillance (AS) has become a well-accepted and widely used
treatment strategy. Objective To assess the long-term safety of AS for men with screen …

Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort

LF Newcomb, IM Thompson, HD Boyer… - The Journal of …, 2016 - auajournals.org
Purpose: Active surveillance represents a strategy to address the overtreatment of prostate
cancer, yet uncertainty regarding individual patient outcomes remains a concern. We …

How active is active surveillance? Intensity of followup during active surveillance for prostate cancer in the United States

S Loeb, D Walter, C Curnyn, HT Gold… - The Journal of …, 2016 - auajournals.org
Purpose: While major prostate cancer active surveillance programs recommend repeat
testing such as prostate specific antigen and prostate biopsy, to our knowledge compliance …

Active surveillance for prostate cancer

J Romero‐Otero, B García‐Gómez… - … Journal of Urology, 2016 - Wiley Online Library
It is worth distinguishing between the two strategies of expectant management for prostate
cancer. Watchful waiting entails administering non‐curative androgen deprivation therapy to …

[HTML][HTML] Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma

CF Kweldam, IP Kümmerlin, D Nieboer… - European Journal of …, 2016 - Elsevier
Aim of the study Gleason score (GS) 3+ 4= 7 prostate cancer patients with presence of
cribriform or intraductal carcinoma (7+) have a worse disease-specific survival than those …

Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort

DR Henderson, NM de Souza, K Thomas, SF Riches… - European urology, 2016 - Elsevier
Background In active surveillance (AS) for prostate cancer there are few data on long-term
outcomes associated with novel imaging markers. Objective To determine long-term …